Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer

Xuechen Chen, Jie Ding, Hengjing Li, Prudence R. Carr, Michael Hoffmeister and Hermann Brenner
Cancer Biology & Medicine November 2022, 19 (11) 1586-1597; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0397
Xuechen Chen
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg 69120, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie Ding
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hengjing Li
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
2Medical Faculty Heidelberg, Heidelberg University, Heidelberg 69120, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prudence R. Carr
3School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC 3004, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hoffmeister
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hermann Brenner
1Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
4German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg 69120, Germany
5Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg 69120, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hermann Brenner
  • For correspondence: h.brenner{at}dkfz-heidelberg.de
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Flowchart of inclusion of study participants. BMI, body mass index; CRC, colorectal cancer.

Tables

  • Figures
  • Supplementary Materials
    • View popup
    Table 1

    Characteristics of the study population according to case and control status

    CharacteristicsCRC cases, n (%)Controls, n (%)P value8
    Total4,8443,964
    Age (years), median (Q1, Q3)69 (61, 76)69 (62, 76)
    Gender
     Female1,897 (39.2)1,517 (38.3)
     Male2,947 (60.8)2,447 (61.7)
    School education (years)1<0.0001
     < 93,172 (65.5)2,185 (55.5)
     9–10855 (17.7)837 (21.1)
     > 10808 (16.7)936 (23.6)
    Smoking<0.0001
     Current or former (≥ 30 pack years)1,081 (22.3)706 (17.8)
     Never or former (< 30 pack years)3,763 (77.7)3,258 (82.2)
    Alcohol consumption (g/d), mean (SE)2
     Women5.1 (0.2)5.7 (0.2)<0.0001
     Men22.4 (0.4)19.2 (0.4)<0.0001
    Diet quality score, mean (SE)30.5 (0.1)32.1 (0.1)<0.0001
    Physical activity (MET-hours/week), mean (SE)340.3 (0.6)45.8 (0.7)<0.0001
    BMI (kg/m2)4<0.0001
     Overweight or obese (≥ 25)3,403 (70.3)2,460 (62.1)
     Healthy weight (18.5 to < 25)1,441 (29.7)1,504 (37.9)
    Healthy lifestyle score<0.0001
     054 (1.1)18 (0.5)
     1345 (7.1)174 (4.4)
     21,130 (23.3)686 (17.3)
     31,726 (35.6)1,347 (34.0)
     41,237 (25.5)1,182 (29.8)
     5352 (7.3)557 (14.1)
    Family history of CRC5710 (14.7)431 (10.9)<0.0001
    History of colonoscopy1,282 (26.5)2,386 (60.2)<0.0001
    Participation in routine health check-ups64,123 (85.1)3,646 (92.0)<0.0001
    Regular use of NSAIDs1,394 (28.8)1,509 (38.1)<0.0001
    Cancer sites
     Colon cancer2,950 (60.9)/
     Rectum cancer1,894 (39.1)/
    Cancer stages7
     I1,110 (22.9)/
     II1,476 (30.5)/
     III1,529 (31.6)/
     IV686 (14.2)/

    1Data are missing for 15 participants. 2Lifetime average alcohol consumption, calculated on the basis of self-recalled alcohol consumption at the ages of 20, 30, 40, 50, 60, 70, and 80 years. 3Non-occupational physical activity from the most recent decade preceding the date of diagnosis/interview. 4BMI at approximately 10 years before diagnosis/interview. 5Data are missing for 6 participants. 6Data are missing for 32 participants. 7Data are missing for 43 cases. 8P values are not reported for the matching factors. BMI, body mass index; CRC, colorectal cancer; MET, metabolic equivalent task; NSAID, non-steroidal anti-inflammatory drug; Q, quartile; SE, standard error.

      • View popup
      Table 2

      ORs and GREs for risk of colorectal cancer according to individual lifestyle factors

      Lifestyle factorPointsDescriptionCRC cases, n (%)Controls, n (%)OR (95% CI)1OR (95% CI)2GRE (95% CI)
      Smoking0Smoking: current smoker or former smoker (≥ 30 pack years)1,079 (22.4)704 (17.9)Ref.Ref.Ref.
      1Non-smoking: never smoker or former smoker (< 30 pack years)3,735 (77.6)3,237 (82.1)0.75 (0.67, 0.83)0.86 (0.76, 0.97)−12.3 (−22.5, −2.2)
      P-interaction with PRS3 = 0.61
      Alcohol consumption0Did not meet recommendations on alcoholic drinks41,266 (26.3)911 (23.1)Ref.Ref.Ref.
      1Met recommendation on alcoholic drinks43,548 (73.7)3,030 (76.9)0.83 (0.75, 0.92)0.85 (0.76, 0.95)−13.3 (−22.6, −4.0)
      P-interaction with PRS3 = 0.45
      Diet quality0Unhealthy diet quality: diet quality score < 3453,190 (66.3)2,138 (54.3)Ref.Ref.Ref.
      1Healthy diet quality: diet quality score ≥ 3451,624 (33.7)1,803 (45.7)0.59 (0.54, 0.65)0.69 (0.63, 0.76)−30.4 (−39.4, −21.3)
      P-interaction with PRS3 = 0.17
      Physical activity0Did not meet physical activity guidelines6753 (15.6)486 (12.3)Ref.Ref.Ref.
      1Met physical activity guidelines64,061 (84.4)3,455 (87.7)0.75 (0.66, 0.84)0.95 (0.83, 1.09)−4.2 (−15.6, 7.2)
      P-interaction with PRS3 = 0.35
      BMI0Overweight or obese (BMI ≥ 25 kg/m2)3,384 (70.3)2,447 (62.1)Ref.Ref.Ref.
      1Healthy weight (18.5 < BMI < 25 kg/m2)1,430 (29.7)1,494 (37.9)0.67 (0.61, 0.74)0.67 (0.60, 0.74)−32.8 (−42.2, −23.3)
      P-interaction with PRS3 = 0.36

      1Adjusted for matching factors age and gender. 2Additionally adjusted for school education, family history of CRC, history of colonoscopy, participation in routine health check-ups, use of nonsteroidal anti-inflammatory drugs, PRS (per 10 percentiles, continuous), and mutual adjustment for the other lifestyle factors. 3Interactions were tested by inclusion of a cross-product term of the PRS (continuous variable) and the individual lifestyle factors (categorical variable) along with the main effect terms in multivariable models. 4World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) (2007) Recommendation on alcoholic drinks: ≤ 24 g/day for men and ≤ 12 g/day for women. 5Diet quality score in the highest 40%. 6The WHO Global Recommendations on Physical Activity for Health (2010) recommend that adults engage in at least 150 min of moderate-intensity or 75 min of vigorous-intensity aerobic physical activity throughout the week, or an equivalent combination of moderate and vigorous intensity physical activity (at least ∼500 MET min). BMI, body mass index; CI, confidence intervals; CRC, colorectal cancer; GRE, genetic risk equivalent; OR, odds ratio; PRS, polygenic risk score; Ref., reference.

        • View popup
        Table 3

        Individual associations of the polygenic risk score and the healthy lifestyle score with colorectal cancer risk

        VariablesCRC cases, n (%)Controls, n (%)OR (95%CI)1OR (95% CI)2GRE (95% CI)
        PRS3
         Low1,026 (21.3)1,317 (33.4)Ref.Ref.
         Moderate1,544 (32.1)1,313 (33.3)1.51 (1.35, 1.68)1.54 (1.37, 1.74)
         High2,244 (46.6)1,311 (33.3)2.20 (1.97, 2.44)2.21 (1.97, 2.48)
        PRS (per 10 percentile increase)1.13 (1.11, 1.15)1.13 (1.11, 1.15)
        Healthy lifestyle score
         0–21,519 (31.6)876 (22.2)Ref.Ref.
         31,715 (35.6)1,337 (33.9)0.72 (0.65, 0.81)0.78 (0.69, 0.88)−20.3 (−30.6, −10.0)
         41,233 (25.6)1,175 (29.8)0.57 (0.51, 0.65)0.63 (0.55, 0.72)−37.8 (−49.7, −25.9)
         5347 (7.2)553 (14.0)0.33 (0.28, 0.39)0.38 (0.32, 0.46)−79.2 (−97.3, −61.1)
         Per 1-point increase0.74 (0.71, 0.78)0.78 (0.74, 0.81)−20.3 (−25.0, −15.7)
        P value for interaction between PRS and healthy lifestyle score4 = 0.88/0.39

        1Adjusted for age and gender. 2Additionally adjusted for school education, family history of CRC, history of colonoscopy, participation in routine health check-ups, use of nonsteroidal anti-inflammatory drugs, healthy lifestyle score (categorical variable, for the analysis of PRS), and PRS (continuous variable with per 10 percentile increase, for the analysis of healthy lifestyle score). 3PRS was categorized into low, moderate, and high levels according to tertiles of PRS among controls. 4Interactions were tested by inclusion of a cross-product of the PRS (categorical variable/continuous variable) and the healthy lifestyle score (categorical variable) along with the main effect terms in multivariable models. CI, confidence intervals; CRC, colorectal cancer; OR, odds ratio; PRS, polygenic risk score; Ref., reference.

          • View popup
          Table 4

          ORs and GREs for colorectal cancer risk according to the healthy lifestyle score in subgroups by cancer site and stage

          CRCHealthy lifestyle scoreCases, n (%)Controls, n (%)OR (95% CI)1GRE (95% CI)
          Colon cancer0–2885 (30.2)876 (22.2)Ref.Ref.
          31,060 (36.2)1,337 (33.9)0.79 (0.69, 0.91)−19.3 (−30.7, −7.8)
          4770 (26.3)1,175 (29.8)0.63 (0.55, 0.73)−37.8 (−51.1, −24.6)
          5217 (7.4)553 (14.0)0.39 (0.32, 0.47)−77.0 (−97.3, −56.8)
          Per 1-point increase0.78 (0.74, 0.82)−20.3 (−25.5, −15.1)
          Rectal cancer0–2634 (33.7)876 (22.2)Ref.Ref.
          3655 (34.8)1,337 (33.9)0.75 (0.64, 0.88)−22.0 (−34.7, −9.2)
          4463 (24.6)1,175 (29.8)0.61 (0.51, 0.73)−37.7 (−52.5, −23.0)
          5130 (6.9)553 (14.0)0.37 (0.29, 0.48)−75.9 (−98.7, −53.0)
          Per 1-point increase0.77 (0.73, 0.82)−19.9 (−25.7, −14.2)
          P value for heterogeneity between strata (3/4/5 points) = 0.41/0.57/0.83
          CRC (stage I)0–2309 (28.0)876 (22.2)Ref.Ref.
          3401 (36.3)1,337 (33.9)0.87 (0.72, 1.04)−11.4 (−26.5, 3.7)
          4303 (27.4)1,175 (29.8)0.76 (0.62, 0.92)−22.5 (−39.3, −5.6)
          592 (8.3)553 (14.0)0.49 (0.37, 0.64)−58.4 (−84.0, −32.7)
          Per 1-point increase0.84 (0.79, 0.90)−14.3 (−20.7, −7.9)
          CRC (stage II)0–2501 (34.1)876 (22.2)Ref.Ref.
          3548 (37.3)1,337 (33.9)0.74 (0.62, 0.87)−24.6 (−39.0, −10.3)
          4324 (22.1)1,175 (29.8)0.47 (0.39, 0.57)−61.8 (−81.2, −42.4)
          596 (6.5)553 (14.0)0.32 (0.24, 0.42)−93.2 (−121.7, −64.8)
          Per 1-point increase0.71 (0.67, 0.76)−28.0 (−35.6, −20.4)
          CRC (stage III)0–2464 (30.6)876 (22.2)Ref.Ref.
          3505 (33.3)1,337 (33.9)0.74 (0.63, 0.88)−24.6 (−39.1, −10.1)
          4423 (27.9)1,175 (29.8)0.67 (0.56, 0.80)−32.8 (−48.7, −16.9)
          5124 (8.2)553 (14.0)0.43 (0.33, 0.55)−69.1 (−93.3, −44.8)
          Per 1-point increase0.81 (0.76, 0.86)−17.2 (−23.4, −11.1)
          CRC (stage IV)0–2234 (34.4)876 (22.2)Ref.Ref.
          3244 (35.8)1,337 (33.9)0.77 (0.62, 0.96)−21.4 (−40.1, −2.6)
          4170 (25.0)1,175 (29.8)0.60 (0.47, 0.76)−41.8 (−64.6, −19.0)
          533 (4.8)553 (14.0)0.25 (0.16, 0.37)−113.4 (−157.8, −69.0)
          Per 1-point increase0.72 (0.66, 0.79)−26.9 (−36.8, −17.0)
          P value for heterogeneity between strata (3/4/5 points) = 0.23/0.00015/0.0018

          1Variables in the model included age, gender, school education, family history of CRC, history of colonoscopy, participation in routine health check-ups, use of nonsteroidal anti-inflammatory drugs, healthy lifestyle score, and PRS (per 10 percentiles, continuous). CI, confidence intervals; CRC, colorectal cancer; GRE, genetic risk equivalent; OR, odds ratio; PRS, polygenic risk score; Ref., reference.

          Supplementary Materials

          • Figures
          • Tables
          • [cbm-19-1586-s001.pdf]
          PreviousNext
          Back to top

          In this issue

          Cancer Biology & Medicine: 19 (11)
          Cancer Biology & Medicine
          Vol. 19, Issue 11
          15 Nov 2022
          • Table of Contents
          • Index by author
          Print
          Download PDF
          Email Article

          Thank you for your interest in spreading the word on Cancer Biology & Medicine.

          NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

          Enter multiple addresses on separate lines or separate them with commas.
          The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer
          (Your Name) has sent you a message from Cancer Biology & Medicine
          (Your Name) thought you would like to see the Cancer Biology & Medicine web site.
          Citation Tools
          The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer
          Xuechen Chen, Jie Ding, Hengjing Li, Prudence R. Carr, Michael Hoffmeister, Hermann Brenner
          Cancer Biology & Medicine Nov 2022, 19 (11) 1586-1597; DOI: 10.20892/j.issn.2095-3941.2022.0397

          Citation Manager Formats

          • BibTeX
          • Bookends
          • EasyBib
          • EndNote (tagged)
          • EndNote 8 (xml)
          • Medlars
          • Mendeley
          • Papers
          • RefWorks Tagged
          • Ref Manager
          • RIS
          • Zotero
          Share
          The power of a healthy lifestyle for cancer prevention: the example of colorectal cancer
          Xuechen Chen, Jie Ding, Hengjing Li, Prudence R. Carr, Michael Hoffmeister, Hermann Brenner
          Cancer Biology & Medicine Nov 2022, 19 (11) 1586-1597; DOI: 10.20892/j.issn.2095-3941.2022.0397
          Twitter logo Facebook logo Mendeley logo
          • Tweet Widget
          • Facebook Like
          • Google Plus One

          Jump to section

          • Article
            • Abstract
            • Introduction
            • Materials and methods
            • Results
            • Discussion
            • Conclusions
            • Supporting Information
            • Grant support
            • Conflict of interest statement
            • Author contributions
            • References
          • Figures & Data
          • Info & Metrics
          • References
          • PDF

          Related Articles

          • No related articles found.
          • PubMed
          • Google Scholar

          Cited By...

          • Effectiveness of colorectal cancer screening integrating non-genetic and genetic risk: a prospective study based on UK Biobank data
          • Reducing the global cancer burden with gastrointestinal screening: Chinas 30 years practice
          • Diagnosis of malnutrition in cancer patients
          • Cohort profile: design and methods of the Chinese colorectal, breast, lung, liver, and stomach cancer screening trial (C-BLAST)
          • Google Scholar

          More in this TOC Section

          • Nintedanib enhances tumor cell radiosensitivity by promoting ferroptosis and modulating the ATF4/SLC7A11/GSH axis
          • A novel biguanide-derivative promotes NEDD4-mediated FGFR1 ubiquitination through BMI1 to overcome osimertinib resistance in NSCLC
          • Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters
          Show more Original Article

          Similar Articles

          Keywords

          • Colorectal cancer
          • healthy lifestyle score
          • polygenic risk score
          • family history
          • genetic risk equivalent

          Navigate

          • Home
          • Current Issue

          More Information

          • About CBM
          • About CACA
          • About TMUCIH
          • Editorial Board
          • Subscription

          For Authors

          • Instructions for authors
          • Journal Policies
          • Submit a Manuscript

          Journal Services

          • Email Alerts
          • Facebook
          • RSS Feeds
          • Twitter

           

          © 2025 Cancer Biology & Medicine

          Powered by HighWire